Back
TP53HGNC Autosomal dominantPubMedVUS reclassifiedFunctional SNV

Missense but mis-spliced: germline TP53 variant c.671A > C (p.E224A) and the path from uncertainty to pathogenicity.

Velkova I, Cappato S, Rivera D, et al.Sci Rep 2026 · July 2026
Relevance score
5/10
Disease / domain
Li-Fraumeni syndrome
Source
PubMed
PMID 42463867
Share on LinkedIn

Gene / mechanism

Germline TP53 missense variant c.671A>C disrupting splicing (exon 6 skipping) → frameshift and premature stop codon.

Summary

Characterisation of a germline TP53 variant c.671A>C, located at the penultimate nucleotide of exon 6 and predicted missense (p.E224A), identified in a 2-year-old with retroperitoneal rhabdomyosarcoma and a strong family history suggestive of Li-Fraumeni syndrome. Functional assays in yeast and human cells showed near-wild-type protein activity, but in silico analysis predicted a splicing defect (SpliceAI 0.77). A minigene approach confirmed exon 6 skipping, likely leading to a frameshift and premature stop codon. These data reclassified the variant as likely pathogenic, providing a definitive molecular diagnosis for family counselling.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

A neat demonstration that protein-level readouts can mislead: a variant that looks functionally neutral turns out pathogenic through a splicing mechanism, reconciling SpliceAI and minigene. The message is directly transferable — for a discordant TP53 missense, test splicing before concluding. The impact remains family-level (one variant, one family), hence a moderate score, but the teaching value is real.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 2/3Evidence 2/3Novelty 1/2Sample 0/1Publication 0/1

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 0/1 · Publication status: 0/1 → Total: 5/10

Keywords

TP53Li-Fraumeni syndromesplicingVUS reclassificationrhabdomyosarcoma

More articles on TP53

Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime